Brenda Louise Gallie CM OOnt is a Canadian ophthalmologist. She is the Head of the Retinoblastoma Program in the Hospital for Sick Children (Toronto) Department of Ophthalmology and Vision Sciences.
Brenda Gallie | |
|---|---|
| Spouse | Michael Jewett |
| Academic background | |
| Education | MD, 1969, Queen's University at Kingston |
| Academic work | |
| Institutions | Sick Kids Hospital |
| Main interests | Retinoblastoma |
Early life and education
editGallie completed her medical degree at Queen's University at Kingston in 1969. Following this, she completed her residency and fellowship training at the University of Toronto and a second research fellowship in Immunology and Cancer at the Memorial Sloan-Kettering Cancer Center.[1]
Career
editUpon completing her fellowships, Gallie joined Sick Kids Hospital where she made numerous discoveries about the cancer retinoblastoma.[1] In January 1988, Gallie collaborated with Drs. Robert Phillips and Andy Becker to set up a Retinoblastoma Group in Toronto.[2] This eventually led to the discovery of a new therapy for retinoblastoma.[3] She discovered the fundamental principles of tumor suppressor genes and developed a new methodology to identify the RB1 gene.[1] These tests accurately identified children at risk of developing retinoblastoma before they are born.[4] In 1999, following the discovery of academic misconduct by Gideon Koren, Gallie moved her laboratory to Princess Margaret Hospital. She then opened her laboratory at Toronto Western Hospital a year later.[5] By 2006, Gallie put forward a National Strategy to optimize care for retinoblastoma in Canada. She was also named a Member of the Order of Ontario for being an expert in the treatment of retinoblastoma and contributing to the health care of Canadians.[4]
In 2013, Gallie led a research team that discovered a new and potentially less life-threatening form of retinoblastoma.[6] The following year, Gallie was named a Member of the Order of Canada for her "contributions to the prevention, diagnosis and treatment of retinoblastoma, a childhood eye cancer."[7] She was also recognized with the 2018 Helen Keller Prize for Vision Research[8] and the 2019 Collaborative Leadership Research Grant from the non-profit Uplifting Athletes.[9]
Personal life
editGallie is married to urologist Michael Jewett.[10]
References
edit- ^ a b c "Brenda Gallie". Sick Kids. Retrieved February 10, 2023.
- ^ "Pledge to help in Terry Fox run". Houston Today. September 14, 1988. Retrieved February 10, 2023 – via newspapers.com.
- ^ "Insulin100". University of Toronto. Retrieved February 10, 2023.
- ^ a b "Order of Ontario appointments announced". Government of Ontario. December 12, 2006. Retrieved February 10, 2023.
- ^ Patrick, Kelly (January 9, 2006). "Families fight for eye clinic". National Post. Retrieved February 10, 2023 – via newspapers.com.
- ^ "New form of child's eye tumour identified". Canadian Broadcasting Corporation. March 13, 2013. Retrieved February 10, 2023.
- ^ "Dr. Brenda Louise Gallie". Government of Canada. Retrieved February 10, 2023.
- ^ "The Helen Keller Prize for Vision Research". rbcanadaresearch.com. 2018. Retrieved February 10, 2023.
- ^ "Dr. Brenda Gallie to receive Collaborative Leadership Research Grant at 2019 Young Investigator Draft presented by CSL Behring". Uplifting Athletes. February 26, 2019. Retrieved February 10, 2023.
- ^ "Prizes and Progress in Urology". The Surgical Spotlight. Winter 2011. Retrieved February 10, 2023.
External links
edit- Brenda Gallie publications indexed by Google Scholar